Please Wait...


Upcoming Webinars:

July 16, 2020 - 11:00am (EDT)

As immunotherapies continue to evolve, the assessment of disease progression can be challenging to distinguish from immune response. The concept of immune response and its manifestations on medical imaging can have an impact on determining the course of treatment for the patient.

July 21, 2020 - 11:00am (EDT)

Although often not a component of the initial study plan, a contingency plan can be needed if a study is transitioned because of acquisition at the sponsor level, performance/capability issues or study re-design. When addressing this type of transition or “rescue” scenario, it is important to recognize the unique challenges that a study team will face.

August 6, 2020 - 11:00am (EDT)

Through an industry case study, this webinar will discuss the importance of choosing a vendor who offers a configurable, full-featured solution that can be rapidly implemented.

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica's #ClinicalDataManagement ecosystem of global experts, templates, coding tools and more fills the gap in…
Bioclinica (3 days ago)
Not sure what questions to ask your clinical adjudication provider when transitioning a project to a new provider?…
Bioclinica (3 days ago)
A clinical trial rescue or transition presents a unique set of challenges for study teams. Join us on July 21 for a…
Bioclinica (1 week ago)
Save time and minimize risk with Bioclinica’s Clinical Trial Management System (CTMS) Starter Package. A fully feat…
Bioclinica (2 weeks ago)
It takes a village to manage #clinicaltrial data. Watch our video to learn how to leverage our Clinical…
Bioclinica (2 weeks ago)
The Clinical Trial Management System (CTMS) Starter Package from Bioclinica saves time and minimizes the risk often…
Bioclinica (3 weeks ago)